A new British initiative, TRACD, is positioning itself as a public health-focused pilot project for regulated adult cannabis use. The initiative says it wants to collect data, reduce the risks tied to the illicit market, and give policymakers a more concrete basis for future reform in the UK and the Crown Dependencies of Jersey, Guernsey, and the Isle of Man.
What is TRACD?
TRACD stands for “Transparent, Regulated Adult-Use & Controlled Data.” According to the organization’s own description, it is a controlled model in which adults, if the project is approved, would be able to access quality-assured cannabis products within a pilot framework with clear safety requirements and data collection. The goal is to examine how regulated access works in practice and how it affects public health, society, and the economy.
Get the week’s important news from Cannabis.se in your inbox — interesting weekend reading! 🥦✉️
The background to the initiative
On its website, TRACD says the development gained momentum after the high-profile case of Billy Caldwell in 2018, when his medicine was confiscated at Heathrow. According to the organization, that case helped lead to the legalization of prescription medical cannabis in the UK later that same year. At the same time, TRACD argues that the current model has not led to the broader political progress many had hoped for, and that millions of adults continue to buy cannabis from an unregulated market without quality controls, age limits, or traceable data.
How the model is intended to work
TRACD describes its model as strictly limited in scope. Participation would, if the project is approved, be restricted to people over 21 and preceded by screening. The site also states that the project wants to work with quality-tested products, full traceability from production to dispensing, and anonymized, aggregated data collection on usage patterns, safety, and public health effects. The organization also writes that access in the pilot model would take place through licensed pharmacies.
Public health and harm reduction at the center
A core part of TRACD’s message is that the initiative should not be seen as an ideological campaign, but as a data-driven and public health-oriented project. On the website, the organization highlights harm reduction, consumer protection, and a clear distinction between medical cannabis and adult use outside the healthcare system. TRACD argues that a regulated model could reduce the risks associated with the illicit market while also giving authorities better insight into the effects of a possible reform.
Charlotte Caldwell leads the project
Behind the initiative is Charlotte Caldwell, who is presented as founder and CEO. On the website, her work is described as a continuation of the campaign previously centered on her son Billy’s access to cannabis-based treatment. TRACD also states that the project has support from a network of regional representatives, research and compliance professionals, as well as partners and public supporters from places including Guernsey and the Isle of Man.
A political signal rather than a finished reform
TRACD is not yet asking politicians for a full legal shift, but for permission to carry out a regulated pilot project. That is an important distinction. The strategy appears to be to build an evidence base first and then use the results to influence future cannabis policy in the UK. If the model gains political support, it could become a test case for what a more controlled adult-use market might look like in practice.
Why this could matter
What makes TRACD interesting is that the initiative tries to position the cannabis issue between total prohibition and full commercialization. Instead of advocating an open market, the project emphasizes limited access, follow-up, and traceability. In the British debate, that could help shift the focus from symbolic politics to measurable outcomes. At the same time, the key question remains whether governments and local decision-makers are actually willing to allow such a pilot to move forward. That question is still unanswered on the site.
Sponsor: Sensi Seeds are one of Europe’s most recognized names in premium cannabis genetics, offering a wide selection of feminized, autoflowering, CBD-rich and F1 hybrid seeds for customers who want quality, consistency and choice.